资讯
内科
心血管
肿瘤
内分泌
普通内科
消化
呼吸
神经科
传染科
精神心理
肾内科
风湿免疫
血液科
老年医学
外科
头颈外科
胃肠外科
血管外科
肝胆胰外
骨科
普通外科
胸心外科
神经外科
泌尿外科
烧伤科
整形美容
麻醉疼痛
专科科室
罕见病
康复医学
药械
儿科
耳鼻咽喉
口腔科
眼科
政策人文
营养全科
预防公卫
妇产科
中医科
急重症
皮肤性病
影像放射
转化医学
检验病理
护理
热点
临床研究
研究设计
人工智能
智慧医疗
论文基金
医学科普
药物经济
医生集团
职业安全
患者招募
医学科研
公司产业
医学英语
MedSci动态
指南
按科室浏览
肿瘤科
心血管
传染科
妇产科
神经科
儿科
呼吸
内分泌科
血液科
消化
更多科室
工具
临床工具
临床指南
医学计算与公式
ICD-10/ICD-11疾病编码
医讯达
直播
话题
公开课
精品课
科研工具
期刊数据库查询
期刊智能选择
全球基金查询
文献查询
SCI写作宝典
生物医药大词典
其他工具
下载App使用方便更快捷
Medsci 梅斯搜索
公开课
精品课
服务
科研数智化
直播,公开课与精品课
科研加速器
研究者发起的临床研究(IIS)支持
真实世界研究解决方案
药物经济学
医保准入事务
研究方案设计
数据库建立与管理
药物警戒(PV)
真实世界研究执行
数据统计分析
数字化学术传播解决方案
多渠道营销(MCM)
产品医学策略
学术传播(APO)
其它
积分商城
FAQS
#Pharm#
730篇内容 | 2600人围观
关注话题
话题活跃用户
#
插入话题
插入图片
评论
最新
最热
GetTopicDetailResponse(id=fa03141591e, topicName=Pharm, introduction=Pharm, content=null, image=null, comments=730, allHits=2600, url=https://h5.medsci.cn/topic?id=14159, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=67241, tagList=[TagDto(tagId=67241, tagName=Pharm)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1787313, encodeId=44ce1e8731399, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Int Immunopharmacol:商陆皂苷甲或能治疗神经炎性疾病, objectType=article, longId=111209, objectId=cd751112098f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd751112098f, replyNumber=0, likeNumber=165, createdTime=2017-11-10, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd751112098f, moduleTitle=Int Immunopharmacol:商陆皂苷甲或能治疗神经炎性疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd751112098f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787421, encodeId=f0d71e87421b8, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=J Ocul Pharmacol Ther:布林酰胺1%和溴莫尼定0.2%固定组合在正常眼压性青光眼中的疗效和安全性研究, objectType=article, longId=125640, objectId=89da12564094, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89da12564094, replyNumber=0, likeNumber=71, createdTime=2018-02-01, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89da12564094, moduleTitle=J Ocul Pharmacol Ther:布林酰胺1%和溴莫尼定0.2%固定组合在正常眼压性青光眼中的疗效和安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89da12564094)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787436, encodeId=98fa1e874368b, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=J Pharmacy Pra Res:低剂量阿司匹林怎么吃才能达到更佳效果,近期研究给出解释, objectType=article, longId=128749, objectId=0ed2128e4975, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ed2128e4975, replyNumber=0, likeNumber=69, createdTime=2018-11-22, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ed2128e4975, moduleTitle=J Pharmacy Pra Res:低剂量阿司匹林怎么吃才能达到更佳效果,近期研究给出解释, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ed2128e4975)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787309, encodeId=7b871e87309bd, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=J Ocul Pharmacol Ther:原发性开角型青光眼患者的姿势对眼压和系统血液动力学参数的影响!, objectType=article, longId=110474, objectId=039b1104e4a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=039b1104e4a0, replyNumber=0, likeNumber=93, createdTime=2018-06-24, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=039b1104e4a0, moduleTitle=J Ocul Pharmacol Ther:原发性开角型青光眼患者的姿势对眼压和系统血液动力学参数的影响!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=039b1104e4a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787252, encodeId=29d81e8725290, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacotherapy:抗精神病药超说明书用于心理健康适应证是否适当, objectType=article, longId=98967, objectId=9cf49896e23, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cf49896e23, replyNumber=0, likeNumber=78, createdTime=2017-11-29, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cf49896e23, moduleTitle=Pharmacotherapy:抗精神病药超说明书用于心理健康适应证是否适当, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cf49896e23)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787447, encodeId=e9051e8744791, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Aliment Pharmacol Ther:常规监测的CHB患者HCC检测失败的预测因素, objectType=article, longId=131795, objectId=ac91131e9558, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac91131e9558, replyNumber=0, likeNumber=82, createdTime=2019-02-05, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac91131e9558, moduleTitle=Aliment Pharmacol Ther:常规监测的CHB患者HCC检测失败的预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac91131e9558)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787370, encodeId=a6241e8737020, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacoepidemiol Drug Saf:ACEI/ARB相关的血管性水肿也有种族“歧视”?, objectType=article, longId=118584, objectId=c21b118584ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c21b118584ac, replyNumber=0, likeNumber=67, createdTime=2018-01-21, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c21b118584ac, moduleTitle=Pharmacoepidemiol Drug Saf:ACEI/ARB相关的血管性水肿也有种族“歧视”?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c21b118584ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787364, encodeId=89ca1e873642c, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Clin Psychopharm Neurosci:病例报告:鲁拉西酮高剂量可诱发中性粒细胞减少症, objectType=article, longId=118401, objectId=7dd2118401e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7dd2118401e8, replyNumber=0, likeNumber=70, createdTime=2017-12-26, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7dd2118401e8, moduleTitle=Clin Psychopharm Neurosci:病例报告:鲁拉西酮高剂量可诱发中性粒细胞减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7dd2118401e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787254, encodeId=386e1e8725472, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacotherapy:慢性阻塞性肺病:LABA/LAMA还是LABA/ICS?, objectType=article, longId=99192, objectId=5d76991927f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d76991927f, replyNumber=0, likeNumber=65, createdTime=2017-11-17, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d76991927f, moduleTitle=Pharmacotherapy:慢性阻塞性肺病:LABA/LAMA还是LABA/ICS?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d76991927f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787448, encodeId=de511e8744830, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmazie:马来酸伊索拉定和阿奇霉素联合治疗可预防牙周炎的进展, objectType=article, longId=132139, objectId=e23b13213918, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e23b13213918, replyNumber=0, likeNumber=86, createdTime=2018-11-06, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e23b13213918, moduleTitle=Pharmazie:马来酸伊索拉定和阿奇霉素联合治疗可预防牙周炎的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e23b13213918)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787433, encodeId=2d291e87433f0, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=PHARMACOEPIDEM DR S:11%的布洛芬用户剂量超标, objectType=article, longId=127959, objectId=e1f812e959d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1f812e959d7, replyNumber=0, likeNumber=68, createdTime=2018-05-16, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1f812e959d7, moduleTitle=PHARMACOEPIDEM DR S:11%的布洛芬用户剂量超标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1f812e959d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787379, encodeId=48b81e8737948, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Neuropsychopharmacology:为啥肥胖会不开心, objectType=article, longId=119918, objectId=7a2a11991889, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a2a11991889, replyNumber=0, likeNumber=67, createdTime=2018-10-03, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a2a11991889, moduleTitle=Neuropsychopharmacology:为啥肥胖会不开心, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a2a11991889)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787286, encodeId=6a431e8728645, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Ann Pharmacother:基于指南证据评估ICU超说明书用药特征, objectType=article, longId=104444, objectId=d6e8104444e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6e8104444e6, replyNumber=0, likeNumber=82, createdTime=2018-05-27, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6e8104444e6, moduleTitle=Ann Pharmacother:基于指南证据评估ICU超说明书用药特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6e8104444e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787363, encodeId=cbe21e873634d, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacoepidemiol Drug Saf:选择性COX-2抑制剂或传统NSAIDs单独使用或联用PPIs患者的胃肠道毒性, objectType=article, longId=118181, objectId=7381118181a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7381118181a9, replyNumber=0, likeNumber=72, createdTime=2018-02-27, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7381118181a9, moduleTitle=Pharmacoepidemiol Drug Saf:选择性COX-2抑制剂或传统NSAIDs单独使用或联用PPIs患者的胃肠道毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7381118181a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787353, encodeId=6a6a1e87353d5, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Psychiat Clin Psychopharm:病例报道--文拉法辛诱导的前列腺疾病, objectType=article, longId=117465, objectId=296311e46543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=296311e46543, replyNumber=0, likeNumber=68, createdTime=2018-05-22, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=296311e46543, moduleTitle=Psychiat Clin Psychopharm:病例报道--文拉法辛诱导的前列腺疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=296311e46543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787272, encodeId=a9d81e8727226, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Int J Pharm.:通过嵌入具有持续释放特性的不耐热治疗剂载体优化HPMC眼药, objectType=article, longId=102569, objectId=f3ce10256901, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3ce10256901, replyNumber=0, likeNumber=82, createdTime=2018-04-20, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3ce10256901, moduleTitle=Int J Pharm.:通过嵌入具有持续释放特性的不耐热治疗剂载体优化HPMC眼药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3ce10256901)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787417, encodeId=4af81e8741738, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacotherapy:辅助β-内酰胺联合万古霉素能否降低MRSA血液感染的临床失败率?, objectType=article, longId=124960, objectId=ecbc12496029, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecbc12496029, replyNumber=0, likeNumber=88, createdTime=2018-06-07, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecbc12496029, moduleTitle=Pharmacotherapy:辅助β-内酰胺联合万古霉素能否降低MRSA血液感染的临床失败率?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecbc12496029)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787401, encodeId=94b31e874019b, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Biomed Pharmacother:特立帕肽可促进新生血管形成, objectType=article, longId=122537, objectId=237412253e9e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=237412253e9e, replyNumber=0, likeNumber=78, createdTime=2018-10-21, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=237412253e9e, moduleTitle=Biomed Pharmacother:特立帕肽可促进新生血管形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=237412253e9e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787450, encodeId=3c661e8745070, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=ACC 2018:PHARMCLO研究:抗血小板药物的精准治疗年代来临了吗?, objectType=article, longId=132456, objectId=1c5e1324564c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c5e1324564c, replyNumber=0, likeNumber=75, createdTime=2018-05-26, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c5e1324564c, moduleTitle=ACC 2018:PHARMCLO研究:抗血小板药物的精准治疗年代来临了吗?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c5e1324564c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787405, encodeId=90721e8740531, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Eur Rev Med Pharmacol Sci:缺氧刺激通过上调HIF-1α/ MMP9信号通路促进视网膜母细胞瘤细胞体外侵袭!, objectType=article, longId=123840, objectId=086c12384079, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=086c12384079, replyNumber=0, likeNumber=82, createdTime=2018-05-26, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=086c12384079, moduleTitle=Eur Rev Med Pharmacol Sci:缺氧刺激通过上调HIF-1α/ MMP9信号通路促进视网膜母细胞瘤细胞体外侵袭!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=086c12384079)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯话题小助手
关注
已关注
Pharm
2020-05-29
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Int Immunopharmacol:商陆皂苷甲或能治疗神经炎性疾病
165
0
2017-11-10
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
J Ocul Pharmacol Ther:布林酰胺1%和溴莫尼定0.2%固定组合在正常眼压性青光眼中的疗效和安全性研究
71
0
2018-02-01
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
J Pharmacy Pra Res:低剂量阿司匹林怎么吃才能达到更佳效果,近期研究给出解释
69
0
2018-11-22
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
J Ocul Pharmacol Ther:原发性开角型青光眼患者的姿势对眼压和系统血液动力学参数的影响!
93
0
2018-06-24
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Pharmacotherapy:抗精神病药超说明书用于心理健康适应证是否适当
78
0
2017-11-29
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Aliment Pharmacol Ther:常规监测的CHB患者HCC检测失败的预测因素
82
0
2019-02-05
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Pharmacoepidemiol Drug Saf:ACEI/ARB相关的血管性水肿也有种族“歧视”?
67
0
2018-01-21
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Clin Psychopharm Neurosci:病例报告:鲁拉西酮高剂量可诱发中性粒细胞减少症
70
0
2017-12-26
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Pharmacotherapy:慢性阻塞性肺病:LABA/LAMA还是LABA/ICS?
65
0
2017-11-17
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Pharmazie:马来酸伊索拉定和阿奇霉素联合治疗可预防牙周炎的进展
86
0
2018-11-06
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
PHARMACOEPIDEM DR S:11%的布洛芬用户剂量超标
68
0
2018-05-16
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Neuropsychopharmacology:为啥肥胖会不开心
67
0
2018-10-03
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Ann Pharmacother:基于指南证据评估ICU超说明书用药特征
82
0
2018-05-27
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Pharmacoepidemiol Drug Saf:选择性COX-2抑制剂或传统NSAIDs单独使用或联用PPIs患者的胃肠道毒性
72
0
2018-02-27
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Psychiat Clin Psychopharm:病例报道--文拉法辛诱导的前列腺疾病
68
0
2018-05-22
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Int J Pharm.:通过嵌入具有持续释放特性的不耐热治疗剂载体优化HPMC眼药
82
0
2018-04-20
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Pharmacotherapy:辅助β-内酰胺联合万古霉素能否降低MRSA血液感染的临床失败率?
88
0
2018-06-07
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Biomed Pharmacother:特立帕肽可促进新生血管形成
78
0
2018-10-21
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
ACC 2018:PHARMCLO研究:抗血小板药物的精准治疗年代来临了吗?
75
0
2018-05-26
回复
jj000001
(审核中...)
关注
已关注
前往app查看评论内容
#Pharm#
Eur Rev Med Pharmacol Sci:缺氧刺激通过上调HIF-1α/ MMP9信号通路促进视网膜母细胞瘤细胞体外侵袭!
82
0
2018-05-26
回复
共500条
首页
上一页
下一页
尾页
页码:
25
/25页
20条/页
扫描二维码下载梅斯医学APP
科室
订阅+
更多科室
工具
服务